(Q36531325)

14 August 2017

1 reference

3 April 2019

Current staging of hepatocellular carcinoma: imaging implications (English)

1 reference

14 August 2017

hepatocellular carcinoma

1 reference

3 April 2019

1 reference

3 April 2019

Bhosale P

1

1 reference

14 August 2017

Szklaruk J

series ordinal

2

1 reference

14 August 2017

Silverman PM

series ordinal

3

1 reference

14 August 2017

4 July 2006

2 references

14 August 2017

3 April 2019

1 reference

14 August 2017

6

1 reference

14 August 2017

83-94

1 reference

Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma.

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693764

Staging and current treatment of hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693764

Percutaneous image-guided radiofrequency ablation in the therapeutic management of hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693764

Alpha-fetoprotein expression is a potential prognostic marker in hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693764

The continuing challenge of hepatic cancer in Asia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693764

Phase II study with a combination of epirubicin, cisplatin, UFT, and leucovorin in advanced hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693764

Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693764

Histopathology of liver cancers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693764

Role of computerized tomography in the staging of gastrointestinal neoplasms

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693764

Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693764

Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693764

Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693764

Hypervascular hepatocellular carcinoma: can double arterial phase imaging with multidetector CT improve tumor depiction in the cirrhotic liver?

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693764

Extrahepatic Metastases of Hepatocellular Carcinoma

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693764

Hepatocellular Carcinoma: Role of Unenhanced and Delayed Phase Multi–Detector Row Helical CT in Patients with Cirrhosis

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693764

Aggressive multimodality treatment for intra-hepatic recurrence of hepatocellular carcinoma following hepatic resection

4 December 2018

1 reference

12 December 2020

[Epidemiology, natural history and pathogenesis of hepatocellular carcinoma]

1 reference

12 December 2020

Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging

1 reference

12 December 2020

Oral contraceptives and liver cancer. Results of the Multicentre International Liver Tumor Study (MILTS)

1 reference

12 December 2020

Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observations

1 reference

12 December 2020

Predictive Factors of Outcome After Liver Transplantation in Patients With Cirrhosis and Hepatocellular Carcinoma

1 reference

12 December 2020

[Transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma]

1 reference

12 December 2020

10.1102/1470-7330.2006.0014

Identifiers

DOI

1 reference

release_qu322oiugfejtjl2aajihkf7se

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qu322oiugfejtjl2aajihkf7se

24 November 2022

mapped directly with Wikidata item

1 reference

14 August 2017

PubMed publication ID

16829469

1 reference